Foresight, founded in 2016, is a full-service mental health care organization aiming to make mental health care more accessible and affordable through increased partnerships with insurance companies. Foresight’s services include traditional therapy, as well as treatment for other conditions, like anxiety, ADHD, depression, and nutrition.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
07/20/2022 | Series C | $56MM | $xx.xx | $276.15MM | Sequoia Capital | |
Price per Share
$xx.xx
Shares Outstanding
4,272,852
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Sequoia Capital
|
||||||
07/31/2021 | Series B-1 | $25MM | $xx.xx | $498.88MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
758,797
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.1x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
01/31/2021 | Series B | $25MM | $xx.xx | $196.88MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
2,402,871
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
08/11/2020 | Series A-1 | $6.52MM | $xx.xx | $58.73MM | Polaris Partners, What If Ventures, Town Hall Ventures, BioVerge | |
Price per Share
$xx.xx
Shares Outstanding
1,913,151
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Polaris Partners, What If Ventures, Town Hall Ventures, BioVerge
|
||||||
10/31/2017 | Series A-4 | $5.08MM | $xx.xx | $58.73MM | Polaris Partners, What If Ventures, Town Hall Ventures, BioVerge | |
Price per Share
$xx.xx
Shares Outstanding
1,862,043
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Polaris Partners, What If Ventures, Town Hall Ventures, BioVerge
|
||||||
10/31/2017 | Series A-3 | $1.23MM | $xx.xx | $58.73MM | Polaris Partners, What If Ventures, Town Hall Ventures, BioVerge | |
Price per Share
$xx.xx
Shares Outstanding
868,950
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Polaris Partners, What If Ventures, Town Hall Ventures, BioVerge
|
||||||
10/31/2017 | Series A-2 | $559,199 | $xx.xx | $58.73MM | Polaris Partners, What If Ventures, Town Hall Ventures, BioVerge | |
Price per Share
$xx.xx
Shares Outstanding
522,226
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Polaris Partners, What If Ventures, Town Hall Ventures, BioVerge
|